Governance, Regulatory & Verification Terms
Institutional governance terms, regulatory licensing commitments, and credential verification notices governing the Zohra Health Group Proposal.
Corporate, Clinical & Regulatory Governance Charter
These terms outline the regulatory compliance framework, phased service activation gates, and mandatory verification disclosures of Zohra Health Group across the United States and Canada.
Institutional Purpose & Proposal Scope
This platform presents the official Investment, Partnership & Healthcare Development Proposal of Zohra Health Group for the establishment of an initial outpatient medical centre (Stage A) and phased expansion into a multi-specialty hospital network (Stages B–E) in the United States and Canada.
All clinical services, diagnostic capabilities, and inpatient hospital departments described herein are subject to applicable federal, state, provincial, and municipal healthcare licensing prior to operational launch.
Section 6 Mandatory Leadership & Credential Verification Protocol
Section 6 of the Zohra Health Group Proposal identifies Founder Dr. Sarah, Board of Directors (Dr. Danish Mushtaq, Sakandar Hayat, and Dr. Laraib Usman), Health Director Dr. Awias Ur Rehman, Project Lead Neil Robert, and Team Management (HR, HR Executive, and target clinical/corporate management roles in Section 8).
United States & Canada Regulatory Compliance
Zohra Health Group is committed to full compliance with all healthcare statutes in its target jurisdictions:
Clinical Governance & Patient Safety Mandate (Section 13)
Every clinical encounter is governed by written standard operating procedures, licensed physician/nurse credentialing, two-identifier patient verification, medication safety checks, infection prevention, and documented informed consent.
Phased Expansion & Financial Discipline (Sections 4, 15 & 18)
Progression from Stage A (Initial Outpatient Medical Centre) to Stage B (Multi-Specialty), Stage C (Procedural/Diagnostic), Stage D (Full Hospital), and Stage E (Network) requires formal approval from the Board of Directors and Strategy, Investment & Development Committee based on verified KPIs.